Agenus UK compared the Amperia platform with BLI and SPR for antibody titer analysis in cell line development.

ATUM’s Leap-In platform enables AGC Biologics to offer various cell line development solutions for customers.

Integrated analytical workflows are transforming cell line development by combining faster screening and streamlined decision-making.

New offering provides drug developers with flexible and powerful cell line development options for monoclonal antibodies, multi-specific and complex molecules As drug developers face increasing pressu ...

AGC Biologics is expanding its Cell Line Development Center of Excellence by partnering with ATUM to integrate the Leap-In Transposase expression platform within its offerings.

QuantumScape has completed the installation of key equipment to enable higher-volume QSE-5 cell production – a key goal for ...

Researchers discovered that a long-misunderstood protein plays a key role in helping chromosomes latch onto the right “tracks ...

Genetic variation affects the expression of genes and function of proteins. DNA sequencing technologies have uncovered millions of genetic changes associated with various human traits and disease.

Researchers recently enhanced the titer of a cell line still in development to produce adenovirus viral vectors by 7.5-fold, and without the risk of also producing replication-competent adenoviruses ...

The loss of domvanalimab is the latest in a string of high-profile failures recorded across the biopharma world for the TIGIT ...

As big pharmas including Takeda and Novo Nordisk flee the cell therapy space and smaller biotechs shutter their operations, ...

The Body’s Energy System May Hold The Key To Understanding Condition, Study Shows In A Nutshell What they found: Scientists ...